Report: Diagnosed Cases of AMD in the Seven Major Markets Expected to Grow Over Next 10 Years

Diagnosed prevalent cases of age-related macular degeneration (AMD) in the seven major markets combined is expected to increase from 33.66 million cases in 2021 to 40.32 million in 2031, at an annual growth rate (AGR) of 1.98%, according to GlobalData. 

Of the seven major markets, the diagnosed prevalent cases of AMD in France are expected to increase at an AGR of 2.89% between 2021­ and 2031, followed by Spain (2.85%), and the UK (2.16%).

GlobalData’s latest report, ‘Age-Related Macular Degeneration Epidemiology Analysis and Forecast, 2021-2031’, notes that the major drivers for the spike in the diagnosed prevalent cases of AMD in France is attributable to advancing age, cigarette smoking, diabetes, family history, and cataract surgery.  

*7MM: The US, France, Germany, Italy, Spain, the UK, and Japan